Ziopharm Oncology
ZIOP
#8611
Rank
A$0.26 B
Marketcap
A$1.23
Share price
-0.88%
Change (1 day)
-77.40%
Change (1 year)

Earnings for Ziopharm Oncology (ZIOP)

Earnings in 2021 (TTM): -A$0.12 Billion

According to Ziopharm Oncology's latest financial reports the company's current earnings are A$3.73 Million. In 2020 the company made an earning of -A$0.12 Billion a decrease over its 2019 earnings that were of -A$81.65 Million.

Earnings history for Ziopharm Oncology from 2001 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-A$0.12 Billion4.97%
2020-A$0.12 Billion38.89%
2019-A$81.65 Million7.33%
2018-A$76.08 Million0.77%
2017-A$75.49 Million-67.64%
2016-A$0.24 Billion37.64%
2015-A$0.17 Billion176.1%
2014-A$61.39 Million-24.63%
2013-A$81.45 Million-43.51%
2012-A$0.15 Billion43.09%
2011-A$0.11 Billion190.88%
2010-A$34.64 Million102.46%
2009-A$17.11 Million-52.68%
2008-A$36.16 Million-10.33%
2007-A$40.32 Million15.35%
2006-A$34.96 Million355.36%
2005-A$7.68 Million13788.35%
2004-A$0.06 Million9.27%
2003-A$0.06 Million-10.26%
2002-A$0.06 Million-59.35%
2001-A$0.14 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
A$11.63 B-9,334.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-A$0.39 Billion 202.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$11.33 B-9,098.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Cleveland BioLabs
CBLI
-A$3.89 Million-96.92%๐Ÿ‡บ๐Ÿ‡ธ USA